Skip to main content
Top
Published in: BMC Nephrology 1/2005

Open Access 01-12-2005 | Research article

Progression of kidney disease in type 2 diabetes – beyond blood pressure control: an observational study

Authors: David J Leehey, Holly J Kramer, Tarek M Daoud, Maninder P Chatha, Majd A Isreb

Published in: BMC Nephrology | Issue 1/2005

Login to get access

Abstract

Background

The risk factors for progression of chronic kidney disease (CKD) in type 2 diabetes mellitus (DM) have not been fully elucidated. Although uncontrolled blood pressure (BP) is known to be deleterious, other factors may become more important once BP is treated.

Methods

All patients seen in the outpatient clinics of our hospital between January 1993 and September 2002 with type 2 DM and clinical evidence of CKD were evaluated. Progression of kidney disease was evaluated by rate of decline of glomerular filtration rate (GFR) as estimated from the simplified MDRD formula. Variables associated with progression in univariate analyses were examined by multivariate analysis to determine the factors independently associated with kidney disease progression.

Results

343 patients (mean age 69 years; all male; 77% Caucasian) were studied. Mean BP, glycated hemoglobin, and serum cholesterol during the study period were 138/72 mmHg, 8.1%, and 4.8 mmol/L, respectively. Mean decline of GFR was 4.5 ml min-1 1.73 m2-1 yr-1 (range -14 to +32). Low initial serum albumin (p < 0.001), black race (p < 0.001), and degree of proteinuria (p = 0.002), but not blood pressure, glycated hemoglobin, or serum cholesterol, were independently associated with progression.

Conclusion

In a cohort of diabetic patients with CKD in whom mean BP was < 140/80 mmHg, the potentially remediable factors hypoalbuminemia and proteinuria but not blood pressure were independently associated with progression of kidney disease. Further understanding of the relationship between these factors and kidney disease progression may lead to beneficial therapies in such patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference American Diabetes Association: Nephropathy in Diabetes. Clinical Practice Recommendations. Diabetes Care. 2004, 27 (Suppl 1): S79-83. American Diabetes Association: Nephropathy in Diabetes. Clinical Practice Recommendations. Diabetes Care. 2004, 27 (Suppl 1): S79-83.
2.
go back to reference Ueda H, Ishimura E, Shoji T, et al: Factors affecting progression of renal failure in patients with type 2 diabetes. Diabetes Care. 2003, 26: 1530-1534.CrossRefPubMed Ueda H, Ishimura E, Shoji T, et al: Factors affecting progression of renal failure in patients with type 2 diabetes. Diabetes Care. 2003, 26: 1530-1534.CrossRefPubMed
3.
go back to reference Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving H-H: Progression of nephropathy in type 2 diabetic patients. Kidney Int. 2004, 66: 1596-1605. 10.1111/j.1523-1755.2004.00925.x.CrossRefPubMed Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving H-H: Progression of nephropathy in type 2 diabetic patients. Kidney Int. 2004, 66: 1596-1605. 10.1111/j.1523-1755.2004.00925.x.CrossRefPubMed
4.
go back to reference Bakris GL: The importance of blood pressure control in the patient with diabetes. Am J Med. 2004, 116 (Suppl 5A): 30S-38S. 10.1016/j.amjmed.2003.10.018.CrossRefPubMed Bakris GL: The importance of blood pressure control in the patient with diabetes. Am J Med. 2004, 116 (Suppl 5A): 30S-38S. 10.1016/j.amjmed.2003.10.018.CrossRefPubMed
5.
go back to reference National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease Evaluation, Classification, and Stratification. Am J Kidney Dis. 2002, 39: S76-92. 10.1053/ajkd.2002.30944.CrossRef National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease Evaluation, Classification, and Stratification. Am J Kidney Dis. 2002, 39: S76-92. 10.1053/ajkd.2002.30944.CrossRef
6.
go back to reference Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J (Clin Res Ed). 1982, 285 (6343): 685-688.CrossRef Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J (Clin Res Ed). 1982, 285 (6343): 685-688.CrossRef
7.
go back to reference Parving HH, Andersen AR, Smidt UM, Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet. 1983, 1 (8335): 1175-1179. 10.1016/S0140-6736(83)92462-5.CrossRefPubMed Parving HH, Andersen AR, Smidt UM, Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet. 1983, 1 (8335): 1175-1179. 10.1016/S0140-6736(83)92462-5.CrossRefPubMed
8.
go back to reference Bjorck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M: Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J (Clin Res Ed). 1986, 293 (6545): 471-474.CrossRef Bjorck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M: Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J (Clin Res Ed). 1986, 293 (6545): 471-474.CrossRef
9.
go back to reference Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J (Clin Res Ed). 1987, 294 (6585): 1443-1447.CrossRef Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J (Clin Res Ed). 1987, 294 (6585): 1443-1447.CrossRef
10.
go back to reference Parving HH, Hommel E, Smidt UM: Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ. 1988, 297 (6656): 1086-1091.CrossRefPubMedPubMedCentral Parving HH, Hommel E, Smidt UM: Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ. 1988, 297 (6656): 1086-1091.CrossRefPubMedPubMedCentral
11.
go back to reference Sawicki PT, Muhlhauser I, Didjurgeit U, Berger M: Effects of intensification of antihypertensive care in diabetic nephropathy. J Diabetes Complications. 1995, 9 (4): 315-317. 10.1016/1056-8727(95)80030-I.CrossRefPubMed Sawicki PT, Muhlhauser I, Didjurgeit U, Berger M: Effects of intensification of antihypertensive care in diabetic nephropathy. J Diabetes Complications. 1995, 9 (4): 315-317. 10.1016/1056-8727(95)80030-I.CrossRefPubMed
12.
go back to reference Trocha AK, Schmidtke C, Didjurgeit U, et al: Effects of intensified antihypertensive treatment in diabetic nephropathy: mortality and morbidity results of a prospective controlled 10-year study. J Hypertens. 1999, 17 (10): 1497-1503. 10.1097/00004872-199917100-00019.CrossRefPubMed Trocha AK, Schmidtke C, Didjurgeit U, et al: Effects of intensified antihypertensive treatment in diabetic nephropathy: mortality and morbidity results of a prospective controlled 10-year study. J Hypertens. 1999, 17 (10): 1497-1503. 10.1097/00004872-199917100-00019.CrossRefPubMed
13.
go back to reference UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998, 317: 703-713.CrossRefPubMedCentral UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998, 317: 703-713.CrossRefPubMedCentral
14.
go back to reference Lewis JB, Berl T, Bain RP, Rohde RD, Lewis EJ: Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group. Am J Kidney Dis. 1999, 34: 809-817.CrossRefPubMed Lewis JB, Berl T, Bain RP, Rohde RD, Lewis EJ: Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group. Am J Kidney Dis. 1999, 34: 809-817.CrossRefPubMed
15.
go back to reference Estacio RO, Jeffers BW, Gifford N, Schrier RW: Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care. 2000, 23 (Suppl 2): B54-64.PubMed Estacio RO, Jeffers BW, Gifford N, Schrier RW: Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care. 2000, 23 (Suppl 2): B54-64.PubMed
16.
go back to reference Keane WF, Brenner BM, De Zeeuw D, RENAAL Study Investigators, et al: The risk of developing end-stage renal disease in patients with type2 diabetes and nephropathy: The RENAAL Study. Kidney Int. 2003, 63: 1499-1507. 10.1046/j.1523-1755.2003.00885.x.CrossRefPubMed Keane WF, Brenner BM, De Zeeuw D, RENAAL Study Investigators, et al: The risk of developing end-stage renal disease in patients with type2 diabetes and nephropathy: The RENAAL Study. Kidney Int. 2003, 63: 1499-1507. 10.1046/j.1523-1755.2003.00885.x.CrossRefPubMed
17.
go back to reference Bakris GL, Weir MR, Shanifar S, RENAAL Study Group, et al: Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med. 2003, 163: 1555-1565. 10.1001/archinte.163.13.1555.CrossRefPubMed Bakris GL, Weir MR, Shanifar S, RENAAL Study Group, et al: Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med. 2003, 163: 1555-1565. 10.1001/archinte.163.13.1555.CrossRefPubMed
18.
go back to reference Middleton JP, Lewis J, for the Collaborative Study Group: Predictors of renal outcome in type 2 diabetic nephropathy [abstract]. J Am Soc Nephrol. 2002, 13: 249-250. 10.1159/000057704. Middleton JP, Lewis J, for the Collaborative Study Group: Predictors of renal outcome in type 2 diabetic nephropathy [abstract]. J Am Soc Nephrol. 2002, 13: 249-250. 10.1159/000057704.
19.
go back to reference Tomlinson JW, Owen KR, Close CF: Treating hypertension in diabetic nephropathy. Diabetes Care. 2003, 26: 1802-1805.CrossRefPubMed Tomlinson JW, Owen KR, Close CF: Treating hypertension in diabetic nephropathy. Diabetes Care. 2003, 26: 1802-1805.CrossRefPubMed
20.
go back to reference Dillon JJ: The quantitative relationship between treated blood pressure and progression of diabetic renal disease. Am J Kidney Dis. 1993, 22: 798-802.CrossRefPubMed Dillon JJ: The quantitative relationship between treated blood pressure and progression of diabetic renal disease. Am J Kidney Dis. 1993, 22: 798-802.CrossRefPubMed
21.
go back to reference Yokoyama H, Tomonaga O, Hirayama M, et al: Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting-enzyme inhibitors in NIDDM patients. Diabetologia. 1997, 40: 405-411. 10.1007/s001250050694.CrossRefPubMed Yokoyama H, Tomonaga O, Hirayama M, et al: Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting-enzyme inhibitors in NIDDM patients. Diabetologia. 1997, 40: 405-411. 10.1007/s001250050694.CrossRefPubMed
22.
go back to reference Breyer JA, Bain P, Evans JK, et al: Predictors of progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. Kidney Int. 1996, 50: 1651-1658.CrossRefPubMed Breyer JA, Bain P, Evans JK, et al: Predictors of progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. Kidney Int. 1996, 50: 1651-1658.CrossRefPubMed
23.
go back to reference Gall M-A, Nielsen FS, Smidt UM, et al: The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia. 1993, 36: 1071-1078.CrossRefPubMed Gall M-A, Nielsen FS, Smidt UM, et al: The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia. 1993, 36: 1071-1078.CrossRefPubMed
24.
go back to reference Nelson RG, Bennett PH, Beck GJ, et al: Development and progression of renal disease in Pima Indians with non-insulin-dependent DM. N Engl J Med. 1996, 335: 1636-1642. 10.1056/NEJM199611283352203.CrossRefPubMed Nelson RG, Bennett PH, Beck GJ, et al: Development and progression of renal disease in Pima Indians with non-insulin-dependent DM. N Engl J Med. 1996, 335: 1636-1642. 10.1056/NEJM199611283352203.CrossRefPubMed
25.
go back to reference Klein R, Klein BE, Moss SE, Cruickshanks KJ, Brazy PC: The 10-year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care. 1999, 22: 743-751.CrossRefPubMed Klein R, Klein BE, Moss SE, Cruickshanks KJ, Brazy PC: The 10-year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care. 1999, 22: 743-751.CrossRefPubMed
26.
go back to reference Massy ZA, Khoa TN, Lacour B, Deschamps-Latshca B, Man NK, Jungers P: Dyslipidaemia and progression of renal disease in chronic renal failure patients. Nephrol Dial Transplant. 1999, 14: 2392-2397. 10.1093/ndt/14.10.2392.CrossRefPubMed Massy ZA, Khoa TN, Lacour B, Deschamps-Latshca B, Man NK, Jungers P: Dyslipidaemia and progression of renal disease in chronic renal failure patients. Nephrol Dial Transplant. 1999, 14: 2392-2397. 10.1093/ndt/14.10.2392.CrossRefPubMed
27.
go back to reference Ruggenenti P, Remuzzi G: The role of protein traffic in the progression of renal diseases. Annu Rev Med. 2000, 51: 315-327. 10.1146/annurev.med.51.1.315.CrossRefPubMed Ruggenenti P, Remuzzi G: The role of protein traffic in the progression of renal diseases. Annu Rev Med. 2000, 51: 315-327. 10.1146/annurev.med.51.1.315.CrossRefPubMed
28.
go back to reference Sarnak MJ, Poindexter A, Wang SR, et al: Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. Kidney Int. 2002, 62: 2208-2215. 10.1046/j.1523-1755.2002.00677.x.CrossRefPubMed Sarnak MJ, Poindexter A, Wang SR, et al: Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. Kidney Int. 2002, 62: 2208-2215. 10.1046/j.1523-1755.2002.00677.x.CrossRefPubMed
29.
go back to reference Stenvinkel P, Heimburger O, Paultre F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999, 55: 1899-1911. 10.1046/j.1523-1755.1999.00422.x.CrossRefPubMed Stenvinkel P, Heimburger O, Paultre F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999, 55: 1899-1911. 10.1046/j.1523-1755.1999.00422.x.CrossRefPubMed
30.
go back to reference Kim SB, Yang WS, Park JS: Role of hypoalbuminemia in the genesis of cardiovascular disease in dialysis patients. Perit Dial Int. 1999, 19 (S2): S144-149.PubMed Kim SB, Yang WS, Park JS: Role of hypoalbuminemia in the genesis of cardiovascular disease in dialysis patients. Perit Dial Int. 1999, 19 (S2): S144-149.PubMed
31.
go back to reference Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002, 62: 1524-1538. 10.1046/j.1523-1755.2002.00600.x.CrossRefPubMed Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002, 62: 1524-1538. 10.1046/j.1523-1755.2002.00600.x.CrossRefPubMed
32.
go back to reference Witko-Sarat V, Friedlander M, Nguyen Khoa T, et al: Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 1998, 161: 2524-2532. Witko-Sarat V, Friedlander M, Nguyen Khoa T, et al: Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 1998, 161: 2524-2532.
33.
go back to reference Pereira BJ, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA: Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD, and hemodialysis patients. Kidney Int. 1994, 45: 890-896.CrossRefPubMed Pereira BJ, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA: Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD, and hemodialysis patients. Kidney Int. 1994, 45: 890-896.CrossRefPubMed
34.
go back to reference Stuveling EM, Hillege HL, Bakker SJ, Gans RO, DeJong PE, DeZeeuw D: C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int. 2003, 63: 654-661. 10.1046/j.1523-1755.2003.00762.x.CrossRefPubMed Stuveling EM, Hillege HL, Bakker SJ, Gans RO, DeJong PE, DeZeeuw D: C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int. 2003, 63: 654-661. 10.1046/j.1523-1755.2003.00762.x.CrossRefPubMed
35.
go back to reference Menon V, Wang X, Greene T, et al: Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis. 2003, 42: 44-52. 10.1016/S0272-6386(03)00407-4.CrossRefPubMed Menon V, Wang X, Greene T, et al: Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis. 2003, 42: 44-52. 10.1016/S0272-6386(03)00407-4.CrossRefPubMed
36.
go back to reference Navarro JF, Mora C, Macia M, Garcia J: Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis. 2003, 42: 53-61. 10.1016/S0272-6386(03)00408-6.CrossRefPubMed Navarro JF, Mora C, Macia M, Garcia J: Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis. 2003, 42: 53-61. 10.1016/S0272-6386(03)00408-6.CrossRefPubMed
37.
go back to reference Poggio ED, Wang X, Greene T, Van Lente F, Hall PM: Performance of the Modification of Diet in Renal Disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol. 2005, 16: 459-466. 10.1681/ASN.2004060447.CrossRefPubMed Poggio ED, Wang X, Greene T, Van Lente F, Hall PM: Performance of the Modification of Diet in Renal Disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol. 2005, 16: 459-466. 10.1681/ASN.2004060447.CrossRefPubMed
Metadata
Title
Progression of kidney disease in type 2 diabetes – beyond blood pressure control: an observational study
Authors
David J Leehey
Holly J Kramer
Tarek M Daoud
Maninder P Chatha
Majd A Isreb
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2005
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-6-8

Other articles of this Issue 1/2005

BMC Nephrology 1/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.